Standard BioTools Inc.LABNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-85.63M
↓ 25% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-68.44M
Historical baseline
PeriodValueYoY Change
TTM$-85.63M+27.5%
2024$-118.14M-116.9%
2023$-54.46M+68.6%
2022$-173.57M-292.1%
2021$-44.27M-27.9%
2020$-34.60M+25.8%
2019$-46.62M-50.3%
2018$-31.03M+21.8%
2017$-39.67M+29.7%
2016$-56.42M-